Alexandros Papageorgiou
Papers
1
Total Citations
138
H-Index
1
About
Dr. Alexandros Papageorgiou is a pioneering surgical oncologist whose research focuses on advancing minimally invasive techniques for liver cancer treatment, particularly through robotic surgery. His landmark 2022 study, "Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma," has garnered 138 citations, addressing a critical gap in surgical oncology by providing robust long-term oncologic outcomes data from a Western high-volume center. This work challenges traditional open surgery paradigms, demonstrating that robotic liver resection (RLR) can achieve comparable safety and efficacy while reducing patient morbidity. Dr. Papageorgiou’s contributions extend beyond technical innovation; his research informs evidence-based guidelines for hepatocellular carcinoma management, influencing surgical decision-making globally. By systematically evaluating survival rates, recurrence patterns, and perioperative complications, he has helped validate robotic approaches as a viable standard of care. His work is especially impactful for students and researchers exploring the intersection of technology and oncology, offering a rigorous framework for assessing novel surgical interventions. Dr. Papageorgiou remains a leading voice in the debate over robotic surgery’s role, with his findings shaping future clinical trials and training protocols.
Research Focus
Key Achievements
Top Papers
- 1